LIVIONEX INC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are HENGCHENG PHARMACEUTICAL CO LTD, ELLIPSE PHARMACEUTICALS and MICRODERMIS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Canada | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Medical technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Specific use of cosmetics | |
#5 | Soaps | |
#6 | Object sterilising | |
#7 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Bhushan Rajiv | 11 |
#2 | Goswamy Amit | 11 |
#3 | Gin Jerry | 6 |
#4 | Gin Jerry B | 5 |
#5 | Duffield Christopher | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019153019A1 | Formulations comprising chelators, permeation enhancers and hydroxyethyl cellulose for treating ophthalmic disorders | |
AU2009282456A1 | Method and formulation for treating adverse biological conditions | |
CA2732764A1 | Methods and compositions for treating inflammation and inflammation-related pathologies |